valuation
Today’s 18 Best Dividend Aristocrats Are Today’s Worst Investments
2021-04-09
Introduction The Standard & Poor’s Dividend Aristocrats represent the crème de la crème of dividend growth stocks. These are all companies that have increased their dividend for a minimum of 25 consecutive years. Many of them have consecutively increased their dividends for 30 years, 40 years, 50 years or more. Therefore, they offer a level […]
Is Costco Stock Worth It?
2021-03-19
Introduction Costco (COST) You asked for it, so every Tuesday I do a subscriber request. Today’s video is on Costco, Is Costco Stock Worth It? One of the highest quality companies on the planet and a leader in the “Hypermarkets and Supercenters” subindustry category. Even though Costco has fallen approximately 15% since November of last […]
TOP 6 Utility Stocks For Income and Safety
2021-03-19
Introduction Investing in utility stocks for value safety yield is not always about trying to make the most money that you can. There are other reasons such as income and/or safety that causes people to choose certain investments. Of course, bonds and other fixed income instruments are perfect examples. You buy a bond typically to […]
How to Value Growth Stocks
2021-03-11
Valuing High Growth Stocks Growth stocks are a different breed, and they cannot be valued in the same way you value average businesses. When you are looking at regular businesses, the company’s current valuation is a primary consideration. This is typically measured utilizing metrics such as the P/E ratio, price to cash flows, price to […]
Is the PEG Ratio a Good Valuation Metric or Not?
2021-02-22
Introduction FAST Graphs Analyze Out Loud – is The PEG Ratio a Good Valuation Metric or Not? One of my FAST Graphs’ subscribers asked me where he could find the PEG Ratio on FAST Graphs. The PEG Ratio is a concept, an evaluation metric that I’ve had many discussions with subscribers, individual investors, and even […]
Bristol Myers Squibb (BMY): Unloved & Underappreciated
2021-02-10
Introduction Bristol-Myers Squibb is a leading pharmaceutical company with a strong pipeline. However, the stock is been stagnant in 2020 and therefore remains significantly undervalued here at the beginning of 2021. With this video I attempt to illustrate reasons why the market has been neglecting this blue-chip and then elaborate on whether it is justified […]